0001171843-18-006601.txt : 20180918
0001171843-18-006601.hdr.sgml : 20180918
20180918144825
ACCESSION NUMBER: 0001171843-18-006601
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180914
FILED AS OF DATE: 20180918
DATE AS OF CHANGE: 20180918
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: ROSENBERG MORRIS
CENTRAL INDEX KEY: 0001202786
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-12104
FILM NUMBER: 181075459
MAIL ADDRESS:
STREET 1: C/O SAETTLE GENETICS INC
STREET 2: 21823 30TH DRIVE SE
CITY: BOTHELL
STATE: WA
ZIP: 98021
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: IMMUNOMEDICS INC
CENTRAL INDEX KEY: 0000722830
STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
IRS NUMBER: 611009366
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0630
BUSINESS ADDRESS:
STREET 1: 300 AMERICAN RD
CITY: MORRIS PLAINS
STATE: NJ
ZIP: 07950
BUSINESS PHONE: 9736058200
MAIL ADDRESS:
STREET 1: 300 AMERICAN ROAD
CITY: MORRIS PLAINS
STATE: NJ
ZIP: 07950
4
1
ownership.xml
X0306
4
2018-09-14
0
0000722830
IMMUNOMEDICS INC
IMMU
0001202786
ROSENBERG MORRIS
C/O IMMUNOMEDICS, INC
300 THE AMERICAN ROAD
MORRIS PLAINS
NJ
07950
0
1
0
0
Chief Technology Officer
Stock Options (right to buy)
22.27
2018-09-14
4
A
0
37300
0.0
A
2019-09-14
2025-09-14
Common Stock, par value $0.01 per share
37300
37300
D
The reporting person was granted stock options pursuant to the Company's 2014 Long-Term Incentive Plan. The stock options vest 25% on the first anniversary of the date of grant and on a quarterly basis thereafter over a three year period.
/s/ Morris Rosenberg
2018-09-18